1Paul J Jackson,Martin E.Hugh-Jones,Debra M.Adair,et al.PCR analysis of tissue sample from the 1979 Sverdlovsk anthrax victims:The presence of multiple Bacillus anthracis stain in different victims[J].Proceeding of the National Academy of Science of the USA,1998,95(3):1224.
2Mikesell P.Evidence for plasmid-medicated toxin production in Bacillus anthracis[J].Infect Immun,1983,39(4):371.
3Bret R.Sellman,Michael Mourez,R.John Collier.Diminant-negative mutants of a toxin subunit:An approach to therapy of anthrax[J].Science,2001,292(4):695.
4Mock M.Cloning and expression of the calmodulin-sensitive Bacillus anthracis adenylate cyclase in Escherichia coli[J].Gene,1988,64(3):277.
5Kohout E, Sehat A, Ashraf M. Anthrax: a continuous problem in south west Iran[J]. Am J Med Sci, 1964:247-565
6Muenye KS, Siziya S, Peterson D. Factors associated with human anthrax outbreak in the Chikupo and Ngandu villages of Murewa district in Mashonaland East Province, Zimbabwe[J]. Cent Afr J Med, 1996, 42:312-315
7Centers for Disease Control and Prevention. Summary of notifiable diseases, United states-1994[J]. MMWR, 1994, 43:1-80
8CDC. Notice to readers Ongoing investigation of anthrax-Florida, October 2001[J]. MMWR, 2001,50:877
9CDC. Update: investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001[J]. MMWR, 2001, 50: 889-893
10CDC. Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001[J]. MMWR, 2001, 50: 909-919
